Merck #39;s FDA Delay, Pfizer #39;s Problem NEW YORK - In a capstone to the withdrawal of Vioxx, the US Food and Drug Administration has decided to delay the approval of successor drug Arcoxia until more safety data are available. 
What label best describes this news article? 